I-Sec maintains Sell on Biocon, revises target price to Rs 270

ICICI Securities maintains a 'Sell' call on Biocon, setting a revised target price of Rs 270. Despite a projected earnings CAGR of 91.6% driven by revenue growth, concerns over biosimilar margins and divestment impact EBITDA estimates. Trading at 16.3x FY26E …

Read Full Article →